retatrutide clinical trials phase Trials: 28.7% Weight Loss (TRIUMPH-4) Triple hormone receptor agonist retatrutide

Its also a good option for those who may not tolerate the side effects of the more potent, once-weekly medications

Gault VA, OHarte FP, Harriott P, Flatt PR

It has been demonstrated that weight loss improves many consequences of obesity, and this improvement is greater when weight loss is more important

Actual weight lost is dependent on a number of factors but many Henry Meds patients lose around 5% of their initial body weight

Bypassing the Weight Loss Narrative : Through secondary analyses, Northwestern scientists proved a vital mechanistic point: weight loss alone does not explain the increased risk of low blood pressure